MHC-II neoantigens shape tumour immunity and response to immunotherapy

Elise Alspach(Washington University in St. Louis), Danielle M. Lussier(Washington University in St. Louis), Alexander P. Miceli(Washington University in St. Louis), Ilya Kizhvatov(Washington University in St. Louis), Michel DuPage(Massachusetts Institute of Technology), Adrienne Luoma(Dana-Farber Cancer Institute), Wei Meng(Washington University in St. Louis), Cheryl F. Lichti(Washington University in St. Louis), Ekaterina Esaulova(Washington University in St. Louis), Anthony N. Vomund(Washington University in St. Louis), Daniele Runci(Washington University in St. Louis), Jeffrey P. Ward(Washington University in St. Louis), Matthew M. Gubin(Washington University in St. Louis), Ruan F.V. Medrano(Washington University in St. Louis), Cora D. Arthur(Washington University in St. Louis), J. Michael White(Washington University in St. Louis), Kathleen C. F. Sheehan(Washington University in St. Louis), Alex Chen(Washington University in St. Louis), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Tyler Jacks(Howard Hughes Medical Institute), Emil R. Unanue(Washington University in St. Louis), Maxim N. Artyomov(Washington University in St. Louis), Robert D. Schreiber(University of St Andrews)
Nature
October 23, 2019
Cited by 862Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis